生活方式教育课程作为严重喘患者生物管理的辅助:可行性研究
Joseph W Lanario1, Drew Davies2, Lucy Cartwright1
1Faculty of Health, University of Plymouth, Plymouth, United Kingdom.
PEC innovation
|January 16, 2025
概括
一个适应严重喘的精神教育课程是可行的和有益的. 身体重编程 (BR) 课程有助于管理肺外症状,可以整合到康复计划中.
科学领域:
- 肺部医学 肺部医学
- 心理学 心理学 心理学
背景情况:
- 严重的喘管理往往需要解决肺外症状.
- 心理教育可以为患者提供自我管理策略.
研究的目的:
- 评估适应性精神教育课程的可行性和可接受性,身体重编程 (BR),用于严重喘患者.
- 收集改善BR课程的建议.
主要方法:
- 一个为期四次的在线基于小组的BR课程被交付给严重喘患者.
- 参与者填写了关于生活质量,情绪和症状的前后问卷.
- 对参加至少两次会议的参与者进行了采访.
主要成果:
- 28名参与者完成了课程,其中46%参加了所有课程.
- 回复表明,课程是一个有价值的反思时间,并赞赏小组格式.
- 需要改进的领域包括课程规模,目标和方法.
结论:
- 适应的BR心理教育课程是可行的,并被认为对严重喘患者有益.
- 该课程有效地解决了肺外症状,可以整合到肺部康复计划中.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


